March 07, 2026 09:29 pm (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Iranian drone strike near Dubai Intl. Airport's terminal forces emergency flight suspensions | 26-year-old Hindu man killed after Holi altercation with Muslim neighbour in Delhi’s Uttam Nagar; four arrested | Zohran Mamdani defends wife amid scrutiny over her 'support' for Palestinian cause | Explosions rock club in Kolkata’s Paikpara, locals claim bombs were stored inside | Iran conflict: White House says US could achieve ‘Operation Epic Fury’ objectives in 4–6 weeks | Sensex, Nifty tumble as global tensions and Dow selloff rattle Indian markets | Two IAF pilots killed as Su-30MKI fighter jet crashes in Assam | 'Who is the US to permit?': Congress slams Modi govt over Trump administration’s waiver on India’s Russian oil purchase | US makes surprise move: India gets 30-day waiver to buy Russian oil amid global supply crisis | India edge England by 7 runs in thriller to reach T20 World Cup 2026 final

Sun Pharma announces divestment of US manufacturing units

| | Jun 05, 2016, at 05:25 am
Mumbai, June 4 (IBNS): Sun Pharma on Saturday announced that as a part of its manufacturing consolidation in the US, one of its wholly owned subsidiaries has entered into an agreement with Frontida BioPharm, Inc. for divestment of its two oral solid dosage manufacturing facilities located at Philadelphia, PA, and Aurora, IL both in the US, along with 15 related pharmaceutical products.

"In connection with the transaction, Frontida has agreed to continue manufacturing certain products for Sun Pharma at these facilities on a contract basis for a predetermined period. It has also agreed to offer employment to all production, quality and administrative personnel at the sites. During the divestment process, Sun Pharma was cognizant about ensuring the continued supply of quality products to patients  and protecting the interests of its employees working in these units," read a statement issued by the company.

The impact of this development on Sun Pharma’s consolidated financials and operations is not material.

Other details of the transaction are confidential. 

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.
Related Videos
RBI announces repo rate cut Jun 06, 2025, at 10:51 am
FM Nirmala Sitharaman presents Budget 2025 Feb 01, 2025, at 03:45 pm
Nirmala Sitharaman on Budget 2024 Jul 23, 2024, at 09:30 pm